New ALS screening study aims to Fast-Track patients to trials
NCT ID NCT07400393
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This observational study screens 500 people with early-stage ALS to see if they qualify for specific early-phase clinical trials. Participants undergo tests, genetic analysis, and biomarker checks to match them with the right trial. The study also builds a research database for future ALS studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could speed up matching ALS patients to the right early-phase trials, potentially accelerating development of new treatments.
- What could go wrong
- This is an observational screening study, not a treatment trial. It may not directly benefit participants, and matching depends on trial availability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Wrist sensors and cameras could revolutionize rehab documentation
- Blood markers may unlock early ALS detection — a study puts them to the test
- Brain implant aims to give voice to those trapped in silence
- Nasal spray aims to tame brain inflammation in ALS
- Robotic arm could help people with paralysis regain independence at home